Week in Review: July 14–18

Converting heart muscle to pacemaker cells in pigs; alternative splicing and the human proteome; questioning a reported yogurt mold-illness link; H. pylori swiftly find mouse stomach injuries

Written byTracy Vence
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, GUIDO GERDINGA team led by investigators at the Cedars-Sinai Heart Institute in Los Angeles, California, has devised a way to temporarily turn pig heart muscle into pacemaker cells, opening up the possibility of using this transcription factor-driven approach in patients who—perhaps because of an infection—must have their electronic pacemakers removed. The work was published in Science Translational Medicine this week (July 16).

“This is an exciting preclinical advance that makes the prospect of a biological pacemaker closer to reality,” said Jonathan Epstein, a professor of cardiovascular research at the University of Pennsylvania who was not involved in the study.

WIKIMEDIA, FREDERIC DARDELInvestigating the 20-gene family of aminoacyl tRNA synthetases (AARSs), researchers from the Scripps Research Institute and their colleagues have found nearly 250 protein splice variants, many of which had previously gone undetected. The team reported its results in Science this week (July 17).

“This is an interesting finding and fits into the existing paradigm that, in many cases, a single gene is processed in various ways to have alternative functions,” said Steven Brenner, a computational genomics researcher at the University of California, Berkeley, who was not involved in the work.

MBIO, SOO CHAN LEE ET AL.Microbiologists and food safety experts this week (July 15) highlighted some potential shortcomings in a July 8 mBio paper that blamed a virulent subspecies of Mucor circinelloides for consumer-reported illnesses stemming from a September 2013 yogurt recall in the U.S.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies